ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Immune system evaluation in a cohort of Brazilian patients with head and neck squamous cell carcinoma who are non-smokers and alcoholic beverages abstainers (2024)
Castro Junior, Gilberto de ; Cruz, Lorraynne Letycia Prado ; Passini, Fatima Solange ; Maistro, Simone ; Roela, Rosimeire Aparecida ; Katayama, Maria Lúcia Hirata ; Ribeiro, Ana Carolina Prado ; Santos, Alexandre Bezerra dos; Folgueira, Maria Aparecida Azevedo Koike ; Kowalski, Luiz Paulo ; Lepique, Ana Paula
Source: Journal of Clinical Oncology. Conference titles: AMERICAN SOCIETY OF CLINICAL ONCOLOGY [ASCO] ANNUAL MEETING. Unidades: FM, ICB
Subjects: IMUNOLOGIA, SISTEMA IMUNE, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, ESTUDOS DE COORTES, PACIENTES, TABAGISMO, ESTUDOS PROSPECTIVOS, GRANULÓCITOS, LINFÓCITOS, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO JUNIOR, Gilberto de et al. Immune system evaluation in a cohort of Brazilian patients with head and neck squamous cell carcinoma who are non-smokers and alcoholic beverages abstainers. Journal of Clinical Oncology. Alexandria, VA: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1200/JCO.2024.42.16_suppl.e18030. Acesso em: 06 nov. 2024. , 2024
APA
Castro Junior, G. de, Cruz, L. L. P., Passini, F. S., Maistro, S., Roela, R. A., Katayama, M. L. H., et al. (2024). Immune system evaluation in a cohort of Brazilian patients with head and neck squamous cell carcinoma who are non-smokers and alcoholic beverages abstainers. Journal of Clinical Oncology. Alexandria, VA: Faculdade de Medicina, Universidade de São Paulo. doi:10.1200/JCO.2024.42.16_suppl.e18030
NLM
Castro Junior G de, Cruz LLP, Passini FS, Maistro S, Roela RA, Katayama MLH, Ribeiro ACP, Santos AB dos, Folgueira MAAK, Kowalski LP, Lepique AP. Immune system evaluation in a cohort of Brazilian patients with head and neck squamous cell carcinoma who are non-smokers and alcoholic beverages abstainers [Internet]. Journal of Clinical Oncology. 2024 ; 42 1-1.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.2024.42.16_suppl.e18030
Vancouver
Castro Junior G de, Cruz LLP, Passini FS, Maistro S, Roela RA, Katayama MLH, Ribeiro ACP, Santos AB dos, Folgueira MAAK, Kowalski LP, Lepique AP. Immune system evaluation in a cohort of Brazilian patients with head and neck squamous cell carcinoma who are non-smokers and alcoholic beverages abstainers [Internet]. Journal of Clinical Oncology. 2024 ; 42 1-1.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.2024.42.16_suppl.e18030
Artigo de periodico
Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil (2023)
Vettorazzo, Laura Cristina Sichero ; Gonçalves, Milena Giulia ; Bettoni, Fabiana; Coser, Elisangela Monteiro; Mota, Giana Rabello ; Nunes, Rafaella Almeida Lima ; Mercante, Ana Maria da Cunha; Natalino, Renato José Mendonça ; Uno, Miyuki; Alves, Maria José Ferreira; Kowalski, Luiz Paulo
Source: ORAL ONCOLOGY. Unidade: FM
Subjects: NEOPLASIAS OROFARÍNGEAS, NEOPLASIAS DE CABEÇA E PESCOÇO, INFECÇÕES POR PAPILLOMAVIRUS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VETTORAZZO, Laura Cristina Sichero et al. Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil. ORAL ONCOLOGY, v. 149, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58726. Acesso em: 06 nov. 2024.
APA
Vettorazzo, L. C. S., Gonçalves, M. G., Bettoni, F., Coser, E. M., Mota, G. R., Nunes, R. A. L., et al. (2023). Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil. ORAL ONCOLOGY, 149. doi:10.1016/j.oraloncology.2023.106676
NLM
Vettorazzo LCS, Gonçalves MG, Bettoni F, Coser EM, Mota GR, Nunes RAL, Mercante AM da C, Natalino RJM, Uno M, Alves MJF, Kowalski LP. Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil [Internet]. ORAL ONCOLOGY. 2023 ; 149[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58726
Vancouver
Vettorazzo LCS, Gonçalves MG, Bettoni F, Coser EM, Mota GR, Nunes RAL, Mercante AM da C, Natalino RJM, Uno M, Alves MJF, Kowalski LP. Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil [Internet]. ORAL ONCOLOGY. 2023 ; 149[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58726
Artigo de periodico
Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status (2022)
Sichero, Laura; Tagliabue, Marta; Mota, Giana; Ferreira, Silvaneide; Nunes, Rafaella A. L; Castaneda, Carlos Arturo; Castillo, Miluska; Correa, Rita Mariel; Perdomo, Sandra; Villa, Luisa Lina
Source: Head and neck-journal for the sciences and specialties of the head and neck. Unidade: FM
Subjects: HPV, BIOMARCADORES, NEOPLASIAS DE CABEÇA E PESCOÇO, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SICHERO, Laura et al. Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head and neck-journal for the sciences and specialties of the head and neck, v. 44, n. 1, p. 122-133, 2022Tradução . . Disponível em: https://doi.org/10.1002/hed.26912. Acesso em: 06 nov. 2024.
APA
Sichero, L., Tagliabue, M., Mota, G., Ferreira, S., Nunes, R. A. L., Castaneda, C. A., et al. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head and neck-journal for the sciences and specialties of the head and neck, 44( 1), 122-133. doi:10.1002/hed.26912
NLM
Sichero L, Tagliabue M, Mota G, Ferreira S, Nunes RAL, Castaneda CA, Castillo M, Correa RM, Perdomo S, Villa LL. Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status [Internet]. Head and neck-journal for the sciences and specialties of the head and neck. 2022 ; 44( 1): 122-133.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/hed.26912
Vancouver
Sichero L, Tagliabue M, Mota G, Ferreira S, Nunes RAL, Castaneda CA, Castillo M, Correa RM, Perdomo S, Villa LL. Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status [Internet]. Head and neck-journal for the sciences and specialties of the head and neck. 2022 ; 44( 1): 122-133.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/hed.26912
Artigo de periodico
Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial (2022)
Kauark-Fontes, Elisa; Migliorati, Cesar Augusto; Epstein, Joel B; Treister, Nathaniel Simon; Alves, Carolina Guimaraes Bonfim; Faria, Karina Morais; Palmier, Natalia Rangel; Rodrigues-Oliveira, Leticia; Paglioni, Mariana de Pauli; Castro Junior, Gilberto de Castro
Source: Supportive care in cancer. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, MIOSITE, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAUARK-FONTES, Elisa et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, v. 30, n. 3, p. 2225-2236, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06625-8. Acesso em: 06 nov. 2024.
APA
Kauark-Fontes, E., Migliorati, C. A., Epstein, J. B., Treister, N. S., Alves, C. G. B., Faria, K. M., et al. (2022). Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, 30( 3), 2225-2236. doi:10.1007/s00520-021-06625-8
NLM
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8
Vancouver
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8
Artigo de periodico
Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score (2022)
Burtness, Barbara; Rischin, Danny; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Brana, Irene; Baste, Neus; Neupane, Prakash
Source: Journal of clinical oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURTNESS, Barbara et al. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score. Journal of clinical oncology, v. 40, n. 21, p. 2321-2334, 2022Tradução . . Disponível em: https://doi.org/10.1200/JCO.21.02198. Acesso em: 06 nov. 2024.
APA
Burtness, B., Rischin, D., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2022). Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score. Journal of clinical oncology, 40( 21), 2321-2334. doi:10.1200/JCO.21.02198
NLM
Burtness B, Rischin D, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Baste N, Neupane P. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score [Internet]. Journal of clinical oncology. 2022 ; 40( 21): 2321-2334.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.21.02198
Vancouver
Burtness B, Rischin D, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Baste N, Neupane P. Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score [Internet]. Journal of clinical oncology. 2022 ; 40( 21): 2321-2334.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1200/JCO.21.02198
Artigo de periodico
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 (2022)
Rischin, Danny; Harrington, Kevin J; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Brana, Irene; Neupane, Prakash; Bratland, Ase
Source: Oral oncology. Unidade: FM
Subjects: RECIDIVA LOCAL DE NEOPLASIA, NEOPLASIAS DE CABEÇA E PESCOÇO, RECIDIVA LOCAL DE NEOPLASIA, ENSAIO CLÍNICO, QUIMIOTERAPIA, IMUNOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RISCHIN, Danny et al. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, v. 128, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2022.105815. Acesso em: 06 nov. 2024.
APA
Rischin, D., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, 128. doi:10.1016/j.oraloncology.2022.105815
NLM
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Vancouver
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Artigo de periodico
Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells (2022)
Silva, Luan Cesar; Borgato, Gabriell Bonifacio; Wagner, Vivian Petersen; Martins, Manoela Domingues; Rocha, Guilherme Zweig; Lopes, Marcio Ajudarte; Santos-Silva, Alan Roger; Castro Junior, Gilberto de Castro ; Kowalski, Luiz Paulo; Nor, Jacques E.
Source: Journal of oral pathology & medicine. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, SALIVA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Luan Cesar et al. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, v. 51, n. 6, p. 553-562, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13252. Acesso em: 06 nov. 2024.
APA
Silva, L. C., Borgato, G. B., Wagner, V. P., Martins, M. D., Rocha, G. Z., Lopes, M. A., et al. (2022). Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, 51( 6), 553-562. doi:10.1111/jop.13252
NLM
Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/jop.13252
Vancouver
Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/jop.13252
Artigo de periodico
Induction Chemotherapy for Advanced Oral Cavity Cancer (2021)
Oliveira, Thiago Bueno de; Marta, Gustavo Nader; Castro Junior, Gilberto de ; Kowalski, Luiz Paulo
Source: Current oncology reports. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PROGNÓSTICO, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Thiago Bueno de et al. Induction Chemotherapy for Advanced Oral Cavity Cancer. Current oncology reports, v. 23, n. 11, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11912-021-01119-6. Acesso em: 06 nov. 2024.
APA
Oliveira, T. B. de, Marta, G. N., Castro Junior, G. de, & Kowalski, L. P. (2021). Induction Chemotherapy for Advanced Oral Cavity Cancer. Current oncology reports, 23( 11). doi:10.1007/s11912-021-01119-6
NLM
Oliveira TB de, Marta GN, Castro Junior G de, Kowalski LP. Induction Chemotherapy for Advanced Oral Cavity Cancer [Internet]. Current oncology reports. 2021 ; 23( 11):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11912-021-01119-6
Vancouver
Oliveira TB de, Marta GN, Castro Junior G de, Kowalski LP. Induction Chemotherapy for Advanced Oral Cavity Cancer [Internet]. Current oncology reports. 2021 ; 23( 11):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11912-021-01119-6
Artigo de periodico
Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus (2020)
Morais-Faria, Karina; Palmier, Natalia Rangel; Correia, Jaqueline de Lima; Castro Junior, Gilberto de Castro ; Dias, Reinaldo Brito; Pinto, Henrique da Graca; Lopes, Marcio Ajudarte; Ribeiro, Ana Carolina Prado; Brandao, Thais Bianca; Santos-Silva, Alan Roger
Source: Supportive care in cancer. Unidade: FM
Subjects: ESTOMATITE, ESTUDOS RETROSPECTIVOS, ESTUDOS DE COORTES, NEOPLASIAS DE CABEÇA E PESCOÇO, RADIOTERAPIA, TRISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS-FARIA, Karina et al. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, v. 28, n. 9, p. 4345-4352, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00520-019-05241-x. Acesso em: 06 nov. 2024.
APA
Morais-Faria, K., Palmier, N. R., Correia, J. de L., Castro Junior, G. de C., Dias, R. B., Pinto, H. da G., et al. (2020). Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, 28( 9), 4345-4352. doi:10.1007/s00520-019-05241-x
NLM
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Vancouver
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Artigo de periodico
Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis (2020)
Mariz, Bruno Augusto Linhares Almeida; Kowalski, Luiz Paulo ; William Junior, William Nassib; Castro Junior, Gilberto de Castro ; Chaves, Aline Lauda Freitas; Santos, Marcos; Oliveira, Thiago Bueno de; Araujo, Anna Luiza Damaceno; Normando, Ana Gabriela Costa; Ribeiro, Ana Carolina Prado
Source: Critical reviews in oncology hematology. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, PAPILLOMAVIRIDAE, INFECÇÕES POR PAPILLOMAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIZ, Bruno Augusto Linhares Almeida et al. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Critical reviews in oncology hematology, v. 156, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2020.103116. Acesso em: 06 nov. 2024.
APA
Mariz, B. A. L. A., Kowalski, L. P., William Junior, W. N., Castro Junior, G. de C., Chaves, A. L. F., Santos, M., et al. (2020). Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Critical reviews in oncology hematology, 156. doi:10.1016/j.critrevonc.2020.103116
NLM
Mariz BALA, Kowalski LP, William Junior WN, Castro Junior G de C, Chaves ALF, Santos M, Oliveira TB de, Araujo ALD, Normando AGC, Ribeiro ACP. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis [Internet]. Critical reviews in oncology hematology. 2020 ; 156[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.critrevonc.2020.103116
Vancouver
Mariz BALA, Kowalski LP, William Junior WN, Castro Junior G de C, Chaves ALF, Santos M, Oliveira TB de, Araujo ALD, Normando AGC, Ribeiro ACP. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis [Internet]. Critical reviews in oncology hematology. 2020 ; 156[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.critrevonc.2020.103116
Artigo de periodico
High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia (2020)
Tomo, Saygo; Biss, Stephanye Pinto; Crivelini, Marcelo Macedo; Oliveira, Sandra Helena Penha de; Biasoli, Eder Ricardo; Tjioe, Kellen Cristine; Bernabe, Daniel Galera; Villa, Luisa Lina ; Miyahara, Glauco Issamu
Source: Archives of oral biology. Unidade: FM
Subjects: BIOMARCADORES, CARCINOMA DE CÉLULAS ESCAMOSAS, INFECÇÕES POR PAPILLOMAVIRUS, CICLINAS, LEUCOPLASIA BUCAL, NEOPLASIAS DE CABEÇA E PESCOÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMO, Saygo et al. High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia. Archives of oral biology, v. 115, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.archoralbio.2020.104738. Acesso em: 06 nov. 2024.
APA
Tomo, S., Biss, S. P., Crivelini, M. M., Oliveira, S. H. P. de, Biasoli, E. R., Tjioe, K. C., et al. (2020). High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia. Archives of oral biology, 115. doi:10.1016/j.archoralbio.2020.104738
NLM
Tomo S, Biss SP, Crivelini MM, Oliveira SHP de, Biasoli ER, Tjioe KC, Bernabe DG, Villa LL, Miyahara GI. High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia [Internet]. Archives of oral biology. 2020 ; 115[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.archoralbio.2020.104738
Vancouver
Tomo S, Biss SP, Crivelini MM, Oliveira SHP de, Biasoli ER, Tjioe KC, Bernabe DG, Villa LL, Miyahara GI. High p16(INK4a) immunoexpression is not HPV dependent in oral leukoplakia [Internet]. Archives of oral biology. 2020 ; 115[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.archoralbio.2020.104738
Artigo de periodico-carta/editorial
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] (2020)
Chaves, Aline Lauda Freitas; Castro, Ana Ferreira; Marta, Gustavo Nader; Castro Junior, Gilberto de Castro ; Ferris, Robert L; Giglio, Raul Eduardo; Golusinski, Wojciech; Gorphe, Philippe; Hosal, Sefik; Kowalski, Luiz Paulo
Source: Oral oncology. Unidade: FM
Subjects: CONTROLE DE INFECÇÕES, FATORES DE RISCO, INFECÇÕES POR CORONAVIRUS, NEOPLASIAS DE CABEÇA E PESCOÇO, RESULTADO DE TRATAMENTO, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Aline Lauda Freitas et al. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial]. Oral oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.oraloncology.2020.104734. Acesso em: 06 nov. 2024. , 2020
APA
Chaves, A. L. F., Castro, A. F., Marta, G. N., Castro Junior, G. de C., Ferris, R. L., Giglio, R. E., et al. (2020). Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial]. Oral oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.oraloncology.2020.104734
NLM
Chaves ALF, Castro AF, Marta GN, Castro Junior G de C, Ferris RL, Giglio RE, Golusinski W, Gorphe P, Hosal S, Kowalski LP. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] [Internet]. Oral oncology. 2020 ; 107[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2020.104734
Vancouver
Chaves ALF, Castro AF, Marta GN, Castro Junior G de C, Ferris RL, Giglio RE, Golusinski W, Gorphe P, Hosal S, Kowalski LP. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial] [Internet]. Oral oncology. 2020 ; 107[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2020.104734
Artigo de periodico
Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience (2020)
Franco, Rejane; Matos, Leandro Luongo de; Kulcsar, Marco Aurelio Vamondes; Castro Junior, Gilberto de ; Marta, Gustavo Nader
Source: Clinics. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PERÍODO PÓS-OPERATÓRIO, ESTUDOS RETROSPECTIVOS, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Rejane et al. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1615. Acesso em: 06 nov. 2024.
APA
Franco, R., Matos, L. L. de, Kulcsar, M. A. V., Castro Junior, G. de, & Marta, G. N. (2020). Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, 75. doi:10.6061/clinics/2020/e1615
NLM
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e1615
Vancouver
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 06 ] Available from: https://doi.org/10.6061/clinics/2020/e1615
Artigo de periodico
The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer (2019)
Marchi, Pedro De; Melendez, Matias E; Laus, Ana C; Kuhlmann, Pamela A; Carvalho, Ana Carolina de; Arantes, Lidia Maria R. B; Evangelista, Adriane F; Andrade, Edilene S; Castro Junior, Gilberto de Castro ; Reis, Rui M
Source: Oral oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, POLIMORFISMO, CARCINOMA DE CÉLULAS ESCAMOSAS, SEQUENCIAMENTO GENÉTICO, QUIMIOTERAPIA, ANTINEOPLÁSICOS, PROTEÍNAS DE TRANSPORTE, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHI, Pedro De et al. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, v. 98, p. 48-52, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.09.013. Acesso em: 06 nov. 2024.
APA
Marchi, P. D., Melendez, M. E., Laus, A. C., Kuhlmann, P. A., Carvalho, A. C. de, Arantes, L. M. R. B., et al. (2019). The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, 98, 48-52. doi:10.1016/j.oraloncology.2019.09.013
NLM
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
Vancouver
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
Artigo de periodico
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study (2019)
Burtness, Barbara; Harrington, Kevin J; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Baste, Neus; Neupane, Prakash; Bratland, Ase
Source: Lancet. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, ANTICORPOS MONOCLONAIS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURTNESS, Barbara et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, v. 394, n. 10212, p. 1915-1928, 2019Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(19)32591-7. Acesso em: 06 nov. 2024.
APA
Burtness, B., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394( 10212), 1915-1928. doi:10.1016/S0140-6736(19)32591-7
NLM
Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Baste N, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [Internet]. Lancet. 2019 ; 394( 10212): 1915-1928.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(19)32591-7
Vancouver
Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Baste N, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [Internet]. Lancet. 2019 ; 394( 10212): 1915-1928.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(19)32591-7
Artigo de periodico
Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models (2016)
Oliveira, Érica Aparecida de; Faintuch, Bluma Linkowski; Targino, Roselaine Campos; Moro, Ana Maria; Martinez, Raquel Chacon Ruiz; Pagano, Rosana Lima; Fonoff, Erich Talamoni; Carneiro, Camila de Godoi; Garcez, Alexandre Teles; Faria, Daniele de Paula; Buchpiguel, Carlos Alberto
Source: Amino Acids. Unidade: FM
Subjects: NEOPLASIAS DO SISTEMA NERVOSO, GLIOMA, PEPTÍDEOS, TÉCNICAS CITOLÓGICAS, NEOPLASIAS DE CABEÇA E PESCOÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Érica Aparecida de et al. Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models. Amino Acids, v. 48, n. 3, p. 821-831, 2016Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs00726-015-2130-y. Acesso em: 06 nov. 2024.
APA
Oliveira, É. A. de, Faintuch, B. L., Targino, R. C., Moro, A. M., Martinez, R. C. R., Pagano, R. L., et al. (2016). Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models. Amino Acids, 48( 3), 821-831. doi:10.1007/s00726-015-2130-y
NLM
Oliveira ÉA de, Faintuch BL, Targino RC, Moro AM, Martinez RCR, Pagano RL, Fonoff ET, Carneiro C de G, Garcez AT, Faria D de P, Buchpiguel CA. Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models [Internet]. Amino Acids. 2016 ; 48( 3): 821-831.[citado 2024 nov. 06 ] Available from: http://link.springer.com/article/10.1007%2Fs00726-015-2130-y
Vancouver
Oliveira ÉA de, Faintuch BL, Targino RC, Moro AM, Martinez RCR, Pagano RL, Fonoff ET, Carneiro C de G, Garcez AT, Faria D de P, Buchpiguel CA. Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models [Internet]. Amino Acids. 2016 ; 48( 3): 821-831.[citado 2024 nov. 06 ] Available from: http://link.springer.com/article/10.1007%2Fs00726-015-2130-y
Trabalho de evento-resumo periodico
Radiation therapy in very advanced and unrescectable head-and-neck cancer (IVB/IVC): when to avoid radical treatments? (2013)
Braga, H. Faria; Chen, A. T. T.; Carvalho, I. T.; Marcassa, J. C; Castro, G.; Nadalin, Wladimir
Source: International journal of radiation oncology*biology*physics. Conference titles: Proceedings of the American Society for Radiation Oncology - ASTRO'S. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PESCOÇO (EFEITOS ADVERSOS), RADIAÇÃO (ENERGIA RADIANTE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, H. Faria et al. Radiation therapy in very advanced and unrescectable head-and-neck cancer (IVB/IVC): when to avoid radical treatments?. International journal of radiation oncology*biology*physics. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0360301613019147/1-s2.0-S0360301613019147-main.pdf?_tid=7c4c7922-7ec4-11e3-a8f1-00000aab0f6b&acdnat=1389886991_c6b7e13c375508f384ea254a033b1c5f. Acesso em: 06 nov. 2024. , 2013
APA
Braga, H. F., Chen, A. T. T., Carvalho, I. T., Marcassa, J. C., Castro, G., & Nadalin, W. (2013). Radiation therapy in very advanced and unrescectable head-and-neck cancer (IVB/IVC): when to avoid radical treatments? International journal of radiation oncology*biology*physics. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0360301613019147/1-s2.0-S0360301613019147-main.pdf?_tid=7c4c7922-7ec4-11e3-a8f1-00000aab0f6b&acdnat=1389886991_c6b7e13c375508f384ea254a033b1c5f
NLM
Braga HF, Chen ATT, Carvalho IT, Marcassa JC, Castro G, Nadalin W. Radiation therapy in very advanced and unrescectable head-and-neck cancer (IVB/IVC): when to avoid radical treatments? [Internet]. International journal of radiation oncology*biology*physics. 2013 ; 87( 2): supl. S470.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0360301613019147/1-s2.0-S0360301613019147-main.pdf?_tid=7c4c7922-7ec4-11e3-a8f1-00000aab0f6b&acdnat=1389886991_c6b7e13c375508f384ea254a033b1c5f
Vancouver
Braga HF, Chen ATT, Carvalho IT, Marcassa JC, Castro G, Nadalin W. Radiation therapy in very advanced and unrescectable head-and-neck cancer (IVB/IVC): when to avoid radical treatments? [Internet]. International journal of radiation oncology*biology*physics. 2013 ; 87( 2): supl. S470.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0360301613019147/1-s2.0-S0360301613019147-main.pdf?_tid=7c4c7922-7ec4-11e3-a8f1-00000aab0f6b&acdnat=1389886991_c6b7e13c375508f384ea254a033b1c5f
Trabalho de evento-resumo periodico
Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? (2013)
Caires, I. Q. S.; Lima, R. Caires; Souza, R. Barroso; Souza, K. T.; Negrão, M. V.; Carvalho, H.; Abdo Filho, E.; Hoff, Paulo Marcelo Gehm; Diz, M. D. E.P.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: IDOSOS, NEOPLASIAS DE CABEÇA E PESCOÇO, ESTUDOS RESTROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAIRES, I. Q. S. et al. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly?. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 06 nov. 2024. , 2013
APA
Caires, I. Q. S., Lima, R. C., Souza, R. B., Souza, K. T., Negrão, M. V., Carvalho, H., et al. (2013). Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Caires IQS, Lima RC, Souza RB, Souza KT, Negrão MV, Carvalho H, Abdo Filho E, Hoff PMG, Diz MDEP. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S722.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Caires IQS, Lima RC, Souza RB, Souza KT, Negrão MV, Carvalho H, Abdo Filho E, Hoff PMG, Diz MDEP. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S722.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Malignancy-related hypercalcemia in the bishosphonate era (2013)
Alves, M. F. S.; Mak, M. P.; Piotto, G. H. M.; Takahasi, T. K.; Ramos, R. E. O; Fonseca, L. G.; Mano, Max Senna; Hoff, Paulo Marcelo Gehm; Castro Junior, G.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: CÁLCIO (ANORMALIDADES), NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, M. F. S. et al. Malignancy-related hypercalcemia in the bishosphonate era. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 06 nov. 2024. , 2013
APA
Alves, M. F. S., Mak, M. P., Piotto, G. H. M., Takahasi, T. K., Ramos, R. E. O., Fonseca, L. G., et al. (2013). Malignancy-related hypercalcemia in the bishosphonate era. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Alves MFS, Mak MP, Piotto GHM, Takahasi TK, Ramos REO, Fonseca LG, Mano MS, Hoff PMG, Castro Junior G. Malignancy-related hypercalcemia in the bishosphonate era [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Alves MFS, Mak MP, Piotto GHM, Takahasi TK, Ramos REO, Fonseca LG, Mano MS, Hoff PMG, Castro Junior G. Malignancy-related hypercalcemia in the bishosphonate era [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2024 nov. 06 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) (2010)
Castro, G.; Pasini, F. S.; Siqueira, S. A.; Ferraz, A. R.; Villar, R. C.; Snitcovsky, I. M.; Federico, M. H.
Source: Journal of Clinical Oncology. Conference titles: Annual Meeting of the American Society of Clinical Oncology. Unidade: FM
Subjects: POLIMORFISMO, NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERÁPICOS, PESCOÇO (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540. Acesso em: 06 nov. 2024. , 2010
APA
Castro, G., Pasini, F. S., Siqueira, S. A., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M., & Federico, M. H. (2010). ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540
NLM
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2024 nov. 06 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540
Vancouver
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2024 nov. 06 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540

USP Schools

ReP

Filtros

Document Types

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation